October 1, 2007

Winners of the 2007 IDSA/SHEA Advancements in MRSA Awards
sponsored by Pfizer

Young Investigator Award in MRSA 

The purpose of the award is to provide funding for outstanding clinical or epidemiological research on MRSA.  The total award amount is $200,000 given over a two-year period. The recipient will receive unrestricted funds to support his or her salary, technicians, laboratory supplies, and equipment. 

Clarence “Buddy” Creech III, MD

Project:  Methicillin-Resistant Colonization in Women and Newborns

Special Innovation Awards in MRSA 

The purpose of these awards is to help fund new, innovative projects designed to prevent, diagnose, or treat MRSA.  These awards are given to help clinicians, hospital epidemiologists, or public health officials directly involved in combating MRSA at the institutional or community level.  Two awards of $24,000 each were granted.  These one-time, unrestricted awards to be used to help “seed” new efforts, generate hypotheses, and continuous quality improvement initiatives, health services research, educational efforts, surveillance projects, and other demonstration projects. 

Michelle Barton-Forbes, MD

Project: Predicting the Threshold for Change in Empiric Medical Management of Shin and Soft Tissue Infections in the Era of Community-acquired Methicillin-Resistant Staphylococcus aureus 

Cassandra Salgado, MD

Project:  Providing Evidence of Clonal MRSA Spread to Healthcare Workers to Control Nosocomial Spread of the Organism

Special Recognition Award in MRSA

The purpose of the award is to recognize recent outstanding clinical or epidemiological research that can be expected to make an important contribution toward preventing, diagnosing, or treating MRSA.

Vance Fowler, MD

< Previous Article | Next Article >

Thinking Outside the Box
ART, Circumcision, STI Treatment as HIV Prevention
Global Surveillance, Vaccine Use Key to Controlling Seasonal Influenza
Bad Bugs on the Run
IDSA Advocacy Update
HIV PrEP: Should We or Shouldn’t We?
Keep Up with Drug Approvals, Recalls, Adverse Events
Lyme Disease: When Symptoms Don’t Improve
Alternative Approaches, Possible Vaccines Against MRSA Infections
New Hope for Viral Suppression in All HIV Patients
Resistant Staph: Use One Drug or a Combination?
Congratulations to the 2007 Society Award Recipients
Winners of the 2007 IDSA/SHEA Advancements in MRSA Awards
Congratulations to This Year’s 50 Outstanding Scholars!
IDSA Announces New Board Members
Welcome, New IDSA Members!
Electronic Tools for Infectious Diseases Practitioners
From the President
Public Reporting of HAIs May Have Unintended Consequences
Treatment Options for C. difficile
XDR TB: Where it Came From, Where We’re Going
Search Back Issues
Forward this Issue
Print-Friendly Version

© Copyright IDSA 2008 Infectious Diseases Society of America 1300 Wilson Boulevard, Suite 300 Arlington, VA 22209 info@idsociety.org

Home Page Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA